Abstract

BackgroundCurrent guidelines recommend parvovirus revaccination of adult dogs no more frequently than every 3 years. The aim of this study was to determine the prevalence of dogs showing protective serum antibody titres against canine parvovirus 2 in breeding kennels in Northern Italy and to assess the effect of time from vaccination and the sex of the dog on antibody titres. The study was carried out on 370 animals of different breeds kept in 33 breeding kennels. Antibodies to canine parvovirus 2 in serum samples were measured with an indirect immunoenzymatic assay validated by the manufacturer in relation to the ‘gold standard’ haemagglutination inhibition test. The number of months that had elapsed since the last vaccination was calculated for each animal and categorized into the following classes: < 12 months; 13–24 months; 25–36 months; 37–48 months; and > 49 months.ResultsThe prevalence of ‘unprotected’ dogs was 4.6%. A satisfactory solid herd immunity was present in the majority of breeding kennels, although some vaccination failures were detected. A significant negative correlation was found between antibody titre and months since last vaccination. Comparable antibody titres were found in the first 3 years after vaccination. Although the antibody titre over time was not affected by the sex of the dog, ‘unprotected’ females had been vaccinated more recently than males with analogous low titres.ConclusionsParvovirus revaccination of adult dogs every 3 years, as currently recommended, is also the appropriate recommendation for breeding kennels. Serological tests could be a useful tool to assess the effectiveness of vaccination.

Highlights

  • Current guidelines recommend parvovirus revaccination of adult dogs no more frequently than every 3 years

  • Canine parvovirus type 2 (CPV-2) is the aetiological agent of a severe viral disease in dogs. It emerged as a dog pathogen in the late 1970s, when outbreaks of haemorrhagic gastroenteritis were observed in puppies and young dogs in kennels and shelters worldwide [1]

  • The aim of this study was to determine the prevalence of dogs with protective serum antibody titres against CPV-2 in medium-sized breeding kennels in Piedmont, Northern Italy and to investigate the effect of time from vaccination and the sex of the dog on antibody titres

Read more

Summary

Introduction

Current guidelines recommend parvovirus revaccination of adult dogs no more frequently than every 3 years. The aim of this study was to determine the prevalence of dogs showing protective serum antibody titres against canine parvovirus 2 in breeding kennels in Northern Italy and to assess the effect of time from vaccination and the sex of the dog on antibody titres. Canine parvovirus type 2 (CPV-2) is the aetiological agent of a severe viral disease in dogs. It emerged as a dog pathogen in the late 1970s, when outbreaks of haemorrhagic gastroenteritis were observed in puppies and young dogs in kennels and shelters worldwide [1]. CPV-2 is a nonenveloped single-stranded DNA virus that is closely related to feline parvovirus (FPV) but exhibits more rapid evolution [3].

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.